Skip to main content
CF PharmTech, Inc. logo

CF PharmTech, Inc. — Investor Relations & Filings

Ticker · 2652 HKEX Manufacturing
Open in API
Filings indexed 80 across all filing types
Latest filing 2026-01-26 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2652

About CF PharmTech, Inc.

https://www.cfpharmtech.com

CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It explicitly details the repurchase of shares by the issuer (CF PharmTech, Inc.) on the open market. According to the provided definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-01-26 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It explicitly details the repurchase of 12,000 shares by the issuer (CF PharmTech, Inc.) on 14 January 2026. According to the filing definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-01-14 English
INSIDE INFORMATION FILING WITH THE CSRC FOR PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY THE COMPANY
Share Issue/Capital Change Classification · 1% confidence The document is an announcement regarding a company's application to the CSRC for 'H Share Full Circulation', which involves converting unlisted shares into H shares. This relates to changes in capital structure and share listing status. It does not fit into specific categories like 'Share Issue' (SHA) or 'Delisting' (DLST) perfectly, and it is not a report publication announcement. Given it is a regulatory announcement regarding a specific corporate action involving share conversion and regulatory filing, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for this type of corporate disclosure.
2026-01-12 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It explicitly details the repurchase of shares by the issuer (CF PharmTech, Inc.) on the exchange, including the number of shares, price, and confirmation of compliance with listing rules. This document type is specifically designed for reporting share buybacks and changes in issued/treasury shares, which falls under the 'Transaction in Own Shares' category.
2026-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Transaction in Own Shares Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is specifically used to report monthly movements in a company's issued shares, treasury shares, and share capital. The content explicitly details the repurchase of shares (held as treasury shares) during the month of December 2025. According to the provided definitions, reports of a company buying back its own shares fall under the 'Transaction in Own Shares' (POS) category.
2026-01-05 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It explicitly details the repurchase of 11,000 shares by CF PharmTech, Inc. on 02 January 2026. According to the filing definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-01-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.